SRC and hepatocellular carcinoma: RNA sequencing (RNA‐seq), bioinformatics analysis, co‐immunoprecipitation (co‐IP) assay and in vitro experiments revealed that CD155 interacted with SRC and enhanced SRC activity via CD155/SRC complex formation, subsequently inhibiting p38 MAPK signalling pathway in HCC progression.